Interferon-induced protein with tetratricopeptide repeats 1 (IFIT1) as a prognostic marker for local control in T1-2 N0 breast cancer treated with breast-conserving surgery and radiation therapy (BCS + RT)

Breast Journal

Volumn 19, Issue 3, 2013, Pages 231-239

  Danish, Hasan H ^a   Goyal, Sharad ^a   Taunk, Neil K ^a   Wu, Hao ^a   Moran, Meena S ^b   Haffty, Bruce G ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Early stage breast cancer; interferon induced protein with tetratricopeptide repeats 1; local control; molecular markers; radiation therapy

Indexed keywords

ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; INTERFERON INDUCED PROTEIN WITH TETRATRICOPEPTIDE REPEATS 1; PROGESTERONE RECEPTOR; PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER HORMONE THERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURVIVAL; COHORT ANALYSIS; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LOCAL RECURRENCE FREE SURVIVAL; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PARTIAL MASTECTOMY; PROTEIN EXPRESSION; TISSUE MICROARRAY; TRIPLE NEGATIVE BREAST CANCER;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARRIER PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; TISSUE ARRAY ANALYSIS;

EID: 84876790796     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/tbj.12097     Document Type: Article

References (27)

1. Dunn GP, Koebel CM, Schreiber RD,. Interferons, immunity and cancer immunoediting. Nat Rev Immunol 2006; 6: 836-48.
2. Ikeda H, Old LJ, Schreiber RD,. The roles of IFN gamma in protection against tumor development and cancer immunoediting. Cytokine Growth Factor Rev 2002; 13: 95-109.
3. Bektas N, Noetzel E, Veeck J, et al,. The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancer. Breast Cancer Res 2008; 10: R58.
4. Borden EC, Williams BR,. Interferon-stimulated genes and their protein products: what and how? J Interferon Cytokine Res 2011; 31: 1-4.
5. Kisseleva T, Bhattacharya S, Braunstein J, Schindler CW,. Signaling through the JAK/STAT pathway, recent advances and future challenges. Gene 2002; 285: 1-24.
6. Schindler C, Levy DE, Decker T,. JAK-STAT signaling: from interferons to cytokines. J Biol Chem 2007; 282: 20059-63.
7. Weichselbaum RR, Ishwaran H, Yoon T, et al,. An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer. Proc Natl Acad Sci 2008; 105: 18490-5.
8. Clarke M, Collins R, Darby S, et al,. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005; 366: 2087-106.
9. Vinh-Hung V, Verschraegen C,. Breast-conserving surgery with or without radiotherapy: pooled-analysis for risks of ipsilateral breast tumor recurrence and mortality. J Natl Cancer Inst 2004; 96: 115-21.
10. Recht A, Houlihan MJ,. Conservative surgery without radiotherapy in the treatment of patients with early-stage invasive breast cancer. A review. Ann Surg 1995; 222: 9-18.
11. Fredriksson I, Liljegren G, Palm-Sjovall M, et al,. Risk factors for local recurrence after breast-conserving surgery. Br J Surg 2003; 90: 1093-102.
12. Haffty BG, Yang Q, Reiss M, et al,. Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer. J Clin Oncol 2006; 24: 5652-7.
13. McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM,. REporting recommendations for tumor MARKer prognostic studies (REMARK). Breast Cancer Res Treat 2006; 100: 229-35.
14. Wapnir IL, Anderson SJ, Mamounas EP, Geyer CE Jr, Jeong JH, Tan-Chiu E, Fisher B, Wolmark N,. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials. J Clin Oncol 2006; 24: 2028-37.
15. Taghian A, Jeong JH, Mamounas E, et al,. Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials. J Clin Oncol 2004; 22: 4247-54.
16. Haffty BG,. Molecular and genetic markers in the local-regional management of breast cancer. Semin Radiat Oncol 2002; 12: 329-40.
17. Haffty BG, Glazer PM,. Molecular markers in clinical radiation oncology. Oncogene 2003; 22: 5915-25.
18. Nuyten DS, Kreike B, Hart AA, et al,. Predicting a local recurrence after breast-conserving therapy by gene expression profiling. Breast Cancer Res 2006; 8: R62.
19. Haffty BG, Goyal S,. Molecular subtyping of early-stage breast cancer: implications for radiation therapy. Int J Radiat Oncol Biol Phys 2010; 77: 1293-5.
20. Haffty BG, Buchholz TA,. Molecular predictors of locoregional recurrence in breast cancer: ready for prime time? J Clin Oncol 2010; 28: 1627-9.
21. Fensterl V, Sen GC,. The ISG56/IFIT1 gene family. J Interferon Cytokine Res 2011; 31: 71-8.
22. Wacher C, Muller M, Hofer MJ, et al,. Coordinated regulation and widespread cellular expression of interferon-stimulated genes (ISG) ISG-49, ISG-54, and ISG-56 in the central nervous system after infection with distinct viruses. J Virol 2007; 81: 860-71.
23. Wang C, Pflugheber J, Sumpter R Jr, et al,. Alpha interferon induces distinct translational control programs to suppress hepatitis C virus RNA replication. J Virol 2003; 77: 3898-912.
24. Terenzi F, Saikia P, Sen GC,. Interferon-inducible protein, P56, inhibits HPV DNA replication by binding to the viral protein E1. EMBO J 2008; 27: 3311-21.
25. Guo J, Hui DJ, Merrick WC, Sen GC,. A new pathway of translational regulation mediated by eukaryotic initiation factor 3. EMBO J 2000; 19: 6891-9.
26. Terenzi F, Hui DJ, Merrick WC, Sen GC,. Distinct induction patterns and functions of two closely related interferon-inducible human genes, ISG54 and ISG56. J Biol Chem 2006; 281: 34064-71.
27. Stawowczyk M, Van Scoy S, Kumar KP, Reich NC,. The interferon stimulated gene 54 promotes apoptosis. J Biol Chem 2011; 286: 7257-66.